Liquid Biopsy: How Circulating Tumor DNA Is Changing Cancer Monitoring
Liquid biopsy using circulating tumor DNA (ctDNA) allows non-invasive cancer monitoring through blood tests, offering real-time insights into tumor changes, treatment response, and early recurrence detection. It's replacing invasive biopsies in many cases and is now standard in lung and colorectal cancer care.